Publication
Article
Pharmacy Times
Teva Pharmaceuticals USA (North Wales, Pa)recently announced the introduction and availability ofOfloxacin Tablets. This product is AB-rated and is bioequivalentto Ortho-McNeil?s Floxin tablets. The productis prescribed to patients to reduce the development ofdrug-resistant bacteria and to maintain the effectivenessof this and other antibacterial drugs. Ofloxacin Tablets areindicated for the treatment of adults with mild-to-moderateinfections (unless otherwise indicated) caused bysusceptible strains of designated microorganisms. Theseinfections include chronic bronchitis, community-acquiredpneumonia, and acute pelvic inflammatory disease,among others. Ofloxacin Tablets 200, 300, and 400 mgare available in bottle sizes of 100. For more information,visit www.tevapharmusa.com.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.